Esophageal carcinoma with ductal differentiation combined with multiple myeloma: a case report
- 1Department of Pathology, Hebei Medical University Third Hospital , ,
- 2School of Basic Medicine, Hebei Medical University , ,
Abstract
Esophageal carcinoma with ductal differentiation (ECDD) is a rare esophageal cancer (EC), characterized by distinctive morphological features, including bilayered duct-like structures and a biphenotypic immunophenotype. Multiple myeloma (MM) is a plasma cell neoplasm. The synchronous occurrence of these two entities is exceedingly rare. We report an 80-year-old male who presented with fatigue, anemia, and hypoalbuminemia. Endoscopic examination revealed a high-grade intraepithelial neoplasia of the esophagus. Following endoscopic submucosal dissection, pathological examination confirmed ECDD. Immunohistochemistry demonstrated that the inner layer cells of the duct-like structures were positive for CK7 and CAM5.2, while the outer layer cells were positive for p40 and p63. Concurrently, elevated serum globulin levels prompted further evaluation, leading to a diagnosis of MM. At 13 months postoperatively, no recurrence or metastasis of EC was observed, and the patient’s MM remained stable. This case highlights that in elderly patients presenting with hematological abnormalities, the possibility of coexisting solid malignancy and plasma cell dyscrasia should be considered. ECDD has distinctive pathological features, and accurate recognition is critical to avoid misdiagnosis.
Related
- Combined apparent diffusion coefficient histogram and MRI-based fractal analysis for predicting lymph node metastasis in esophageal squamous cell carcinoma
- Association between absolute lymphocyte count and outcomes of radiotherapy combined with immunotherapy in elderly patients with inoperable esophageal squamous cell carcinoma
- Evaluation of the efficacy and safety of different cycles of neoadjuvant chemotherapy combined with immunotherapy in locally advanced esophageal squamous cell carcinoma: a multi-center, real-world study.
- Tumor-associated calcium signal transducer 2 expression as a promising therapeutic target in esophageal squamous cell carcinoma: a combined the Cancer Genome Atlas and an institutional cohort
- A Pathological Image-Based Pathomics Signature Combined with Clinicopathological Features for Predicting Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma: A Development and External Validation Study
BibTeX
@article{sun2026esophageal,
title = {{Esophageal carcinoma with ductal differentiation combined with multiple myeloma: a case report}},
author = {Hongjing Sun and Minghao Gao and Xiaohui Feng},
journal = {Frontiers in oncology},
year = {2026},
month = sep,
doi = {10.3389/fonc.2026.1922758},
url = {https://europepmc.org/article/PMC/PMC13661365},
note = {CC BY},
}
RIS
TY - JOUR
TI - Esophageal carcinoma with ductal differentiation combined with multiple myeloma: a case report
AU - Hongjing Sun
AU - Minghao Gao
AU - Xiaohui Feng
PY - 2026
DA - 2026/09/30
JO - Frontiers in oncology
DO - 10.3389/fonc.2026.1922758
UR - https://europepmc.org/article/PMC/PMC13661365
AB - Esophageal carcinoma with ductal differentiation (ECDD) is a rare esophageal cancer (EC), characterized by distinctive morphological features, including bilayered duct-like structures and a biphenotypic immunophenotype. Multiple myeloma (MM) is a plasma cell neoplasm. The synchronous occurrence of these two entities is exceedingly rare. We report an 80-year-old male who presented with fatigue, anemia, and hypoalbuminemia. Endoscopic examination revealed a high-grade intraepithelial neoplasia of the esophagus. Following endoscopic submucosal dissection, pathological examination confirmed ECDD. Immunohistochemistry demonstrated that the inner layer cells of the duct-like structures were positive for CK7 and CAM5.2, while the outer layer cells were positive for p40 and p63. Concurrently, elevated serum globulin levels prompted further evaluation, leading to a diagnosis of MM. At 13 months postoperatively, no recurrence or metastasis of EC was observed, and the patient’s MM remained stable. This case highlights that in elderly patients presenting with hematological abnormalities, the possibility of coexisting solid malignancy and plasma cell dyscrasia should be considered. ECDD has distinctive pathological features, and accurate recognition is critical to avoid misdiagnosis.
SN - 2234-943X
ER -